Naganuma T, Iwai T, Takemoto Y, Uchida J, et al. Experience With the Use of a Novel Agent, Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor, for Posttransplant Anemia in Renal Transplant Recipients: A Case Report. Transplant Proc 2022 Feb 1. pii: S0041-1345(21)00920.
PMID: 35120763